Animal and plant proteins and glucose metabolism
Animal and plant proteins and glucose metabolism
批准号:
9904616
负责人:
Samuel Klein
金额:
$56.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-01 至 2024-01-31
关键词:
AcidsAcuteAdultAdverse effectsAliquotAmino AcidsAnimal StructuresAnimalsBiologicalBiopsyBlood GlucoseC-PeptideCell WallChronicComplexConsumptionDataDietDietary ComponentDietary InterventionDietary ProteinsDiseaseEdible PlantsFGF21 geneFabaceaeFoodFortified FoodFutureGTP-Binding ProteinsGlucagonGlucoseGlucose ClampGlucose Plasma ConcentrationGoalsHealthHepaticHormonesHumanHyperinsulinismImpairmentIndicanInfusion proceduresIngestionInsulinInsulin ResistanceIntervention TrialLeadLectin InhibitorLiverMeatMediatingMetabolicMetabolic dysfunctionMusMuscleNon-Insulin-Dependent Diabetes MellitusObesityOralOutcomeParticipantPlant ProteinsPlantsPlasmaPopulation StudyProceduresProductionProtease InhibitorProteinsRandomizedRiskSourceStable Isotope LabelingSulfateTestingTracerUnited StatesValineVascular PlantVolatile Fatty AcidsWomanbaseblood glucose regulationdiabetes riskglucagon-like peptide 1glucose disposalglucose metabolismglucose productionimprovedinsulin secretioninsulin sensitivityinsulin signalingmenmicrobialpreventprotein intakeprotein metabolismprotein metaboliteresponsestool sampletrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Nearly 65% of adults in the United States actively try to increase their protein intake by
consuming naturally protein-rich foods and foods and drinks fortified with protein isolates to
improve their health. However, data from recent population studies have shown high protein
consumption is associated with an increased risk of developing type 2 diabetes (T2D). This
adverse effect might be specific to the type of protein consumed because several studies have
found high animal protein, but not high plant protein, consumption was associated with
increased T2D risk. There is experimental evidence from studies conducted in people and in
mice to support a causal relationship between dietary protein intake and metabolic dysfunction.
However, the effect of chronic high protein intake on glucose homeostasis and the mechanisms
that cause protein-mediated metabolic dysfunction are not known. The reason(s) for the
differences in the metabolic effects observed between high animal protein and high plant protein
consumption are also not known, but could be due to differences in the amino acid composition
and structure of animal and plant proteins per se and/or their biological matrix, which includes
complex cell walls, lectins, and protease inhibitors in protein-rich plant foods, that can impair gut
microbial access to proteins and/or induce the microbial production of beneficial metabolites,
such as short-chain fatty acids. The goal of this proposal is to determine the effect of a high-
protein diet in which the increase in protein intake is derived from different sources (animal vs
plant and protein-rich whole foods vs protein isolates) on: i) liver and muscle insulin sensitivity;
ii) the metabolic response to a meal, and iii) 24-h plasma concentration profiles of glucose,
glucoregulatory hormones, and protein-derived metabolites purported to cause metabolic
dysfunction. Our overarching hypothesis is that diets enriched with either animal or plant protein
isolates, or animal protein-rich whole foods, but not plant protein-rich whole foods, cause
alterations in the plasma hormones and protein metabolites that can cause insulin resistance
and stimulate hepatic glucose production, thereby raising 24-h plasma glucose concentration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exosomes and insulin action in metabolically healthy and unhealthy obesity
-
批准号:10721302
-
项目类别:
-
资助金额:$57.38万
-
财政年份:2023
-
负责人:Samuel Klein
-
依托单位:
Washington University Nutrition Obesity Research Center
-
批准号:10160292
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2020
-
负责人:Samuel Klein
-
依托单位:
Animal and plant proteins and glucose metabolism
-
批准号:9765814
-
项目类别:
-
资助金额:$55.25万
-
财政年份:2019
-
负责人:Samuel Klein
-
依托单位:
Animal and plant proteins and glucose metabolism
-
批准号:10576314
-
项目类别:
-
资助金额:$56.8万
-
财政年份:2019
-
负责人:Samuel Klein
-
依托单位:
Animal and plant proteins and glucose metabolism
-
批准号:10338113
-
项目类别:
-
资助金额:$56.8万
-
财政年份:2019
-
负责人:Samuel Klein
-
依托单位:
Animal and plant proteins and glucose metabolism
-
批准号:10089440
-
项目类别:
-
资助金额:$56.8万
-
财政年份:2019
-
负责人:Samuel Klein
-
依托单位:
Metabolic Effects of Sleep Extension in People with Obesity
-
批准号:10435463
-
项目类别:
-
资助金额:$60.77万
-
财政年份:2018
-
负责人:Samuel Klein
-
依托单位:
Metabolic Effects of Sleep Extension in People with Obesity
-
批准号:10201581
-
项目类别:
-
资助金额:$60.77万
-
财政年份:2018
-
负责人:Samuel Klein
-
依托单位:
NAD+ and metabolic flexibility
-
批准号:10316981
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
NAD+ and metabolic flexibility
-
批准号:10543046
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
NAD+ and metabolic flexibility
-
批准号:10713355
-
项目类别:
-
资助金额:$9.04万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
Assessment of Multiple Dose Administration ofGlucagon Receptor Blocker REMD477 in Type 1 Diabetes
-
批准号:10224813
-
项目类别:
-
资助金额:$99.38万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
NAD+ and metabolic flexibility
-
批准号:10559326
-
项目类别:
-
资助金额:$3.03万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
NAD+ and metabolic flexibility
-
批准号:10777442
-
项目类别:
-
资助金额:$1.94万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
NAD+ and metabolic flexibility
-
批准号:9978503
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
Assessment of the glucagon receptor blocker REMD-477 on insulin requirements in type 1 diabetes
-
批准号:9041432
-
项目类别:
-
资助金额:$22.47万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
Assessment of Multiple Dose Administration ofGlucagon Receptor Blocker REMD477 in Type 1 Diabetes
-
批准号:10018859
-
项目类别:
-
资助金额:$99.38万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
WEIGHT LOSS-INDEPENDENT METABOLIC EFFECTS OF ROUX-EN-Y GASTRIC BYPASS IN DIABETES
-
批准号:8671289
-
项目类别:
-
资助金额:$48.73万
-
财政年份:2014
-
负责人:Samuel Klein
-
依托单位:
WEIGHT LOSS-INDEPENDENT METABOLIC EFFECTS OF ROUX-EN-Y GASTRIC BYPASS IN DIABETES
-
批准号:9306061
-
项目类别:
-
资助金额:$48.73万
-
财政年份:2014
-
负责人:Samuel Klein
-
依托单位:
WEIGHT LOSS-INDEPENDENT METABOLIC EFFECTS OF ROUX-EN-Y GASTRIC BYPASS IN DIABETES
-
批准号:8928175
-
项目类别:
-
资助金额:$48.73万
-
财政年份:2014
-
负责人:Samuel Klein
-
依托单位:
海外基金